OptiBiotix Health (LON:OPTI – Get Free Report) issued its earnings results on Thursday. The company reported GBX (1.52) earnings per share (EPS) for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.
OptiBiotix Health Stock Performance
OPTI stock opened at GBX 5.99 on Thursday. The firm has a market cap of £6.19 million, a PE ratio of -1.56 and a beta of 1.82. The firm has a fifty day moving average price of GBX 5.80 and a 200 day moving average price of GBX 5.74. OptiBiotix Health has a fifty-two week low of GBX 4.50 and a fifty-two week high of GBX 12.25.
OptiBiotix Health Company Profile
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products.
See Also
- Five stocks we like better than OptiBiotix Health
- Enterprise AI to Boost Broadcom’s Software Business? What Industry Data Shows
- IonQ and NVIDIA Just Cracked a Major Quantum Computing Bottleneck
- This Gold ETF Turns a Non-Yielding Asset Into Monthly Income—But There’s a Catch
- Analysts See Double-Digit Upside for These 3 Stocks
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
